This country profile provides an overview of Namibia’s progress in reaching those in need of mass NTD treatment based on 2016 data.

NTD mass treatment coverage index: 1/100
Overall rank: Joint 38th

Treatment coverage

Lymphatic filariasis
N/A
Onchocerciasis
N/A
Schistosomiasis
0%
STH
21%
Trachoma
?
168,000 people received treatment in Namibia in 2016 930,000 people in need did not receive treatment in Namibia in 2016

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Namibia.

Namibia recommendations

These recommendations were given to heads of state at the African Union summit in January 2017 as part of the ALMA Scorecard for Accountability and Action.

  • Implement preventive chemotherapy for schistosomiasis alongside soil-transmitted helminths, at least for school-aged children.
  • Increase budget allocation for neglected tropical diseases at the national level.
  • Provide timely data to the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) to enable monitoring and planning.

Lymphatic filariasis

Namibia does not require mass treatment for lymphatic filariasis.

Onchocerciasis

Namibia does not require mass treatment for onchocerciasis.

Schistosomiasis

Treatment coverage remained the same at 0% in 2015 and 2016.

School-aged children needing treatment
206,000
School-aged children receiving treatment
0 reported

Soil-transmitted helminths

⬆ Treatment coverage increased from 0% in 2015 to 21% in 2016.

Pre-sch and school-aged children needing treatment
811,000
Pre-school and school-aged children receiving treatment
168,000

Trachoma

Namibia may require interventions for trachoma, investigation needed.